Venus Remedies signs MoU for Elores with South African pharmaceutical firm
Expects to generate a cumulative revenue of $20 million within five years of the launch
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
EMA approves new tuberculosis drug delamanid
Otsuka’s phase III clinical trials for delamanid are now underway
Lilly enters branded generics market with launch of Lil Therapeutics
Announces launch of drugs in breast cancer and colo-rectal cancer segment
Cadila Pharmaceuticals and UK’s Helperby Therapeutics in pact
Helperby will supply Cadila Pharmaceuticals with antibiotic resistance breakers
… launches ’Mycidac-C’
The drug is a first in the class active immunotherapy as well as drug targeting Desmocollin-3
Indegene launches US-based healthcare business division
Will focus on engagement, quality, big-data, and payment transformation driven by US health reform
Lupin receives FDA approval for Generic Trizivir tabs
Lupin has received final approval for its Abacavir Sulfate, Lamivudine, and Zidovudine Tablets, 300 mg (base) / 150 mg / 300 mg…
Glenmark launches Hydrocortisone Butyrate cream in the US
Glenmark Generics, USA, the subsidiary of Glenmark Generics, has launched Hydrocortisone Butyrate cream USP, 0.1 per cent in the…
Increasing product offerings with focus on significant opportunity for future revenue growth…
M&A activity in the pharma sector decreases in volume terms and increased in value terms
National annual conference of cancer NGOs and support groups to be held in Mumbai
165 NGOs from India, SAARC countries will participate in the event
Bangalore INDIA NANO puts India on forefront of nanoscience and nanotechnology
Showcases a plethora of discussions, lectures and presentations on nanoscience and nanotechnology
CPhI – India, P – MEC-India show path for success
The 2013 edition witnessed participation from 1000 plus exhibitors from 95 countries
Anand Sharma meets Ireland’s Minister for Jobs, Enterprise and Innovation
More Indian companies including medical device companies, scheduled to set up operations early next year
Biocon, Mylan receive DCGI nod for CANMAb
Biosimilar Trastuzumab will help in the treatment of Her 2+ metastatic breast cancer
Pfizer, Wyeth merger approved
Initiates an important first step towards the creation of a single Pfizer brand in India
Gilead attempts to secure patent on hepatitis C
Is anticipated to receive market approval in the US on Dec 8
Axcellerate Pharma aims to become a market leader in life sciences industry
Establishes CMO/ CRO and API manufacturing facility in New Jersey, US
Venus Remedies receives SFDA approval for meropenem
Plans to launch the product in Saudi Arabia early next year
IPM de-grew 1.7 per cent in October 2013
Valued at Rs 6305 crores, with 10 therapies and 12 regions exceeding market growth rate
Conference highlights need for innovations in OTC
Organisers CubeX, key speaker Nicholas Hall uncover little known aspects of pharma OTC